Abzena Overview
- Year Founded
-
2001
- Status
-
Acquired/Merged
- Employees
-
430
- Latest Deal Type
-
M&A
- Financing Rounds
-
17
- Investments
-
4
Abzena General Information
Description
Manufacturer of complex biologics and bioconjugate services built for de-risking and accelerating drug development from discovery through commercial launch. The company's integrated drug development ecosystem, including cell line platforms, immunogenicity testing, inker-payload conjugation, rapid analytics, and biologics manufacturing facilities, is providing biopharma and biotech clients with end-to-end, scientifically robust, and regulatory-compliant solutions that streamline scale-up and improve time-to-clinic outcomes.
Contact Information
Website
www.abzena.comCorporate Office
- Babraham Research Campus
- Babraham
- Cambridge CB22 3AT
- England, United Kingdom
Corporate Office
- Babraham Research Campus
- Babraham
- Cambridge CB22 3AT
- England, United Kingdom
Abzena Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Abzena Comparisons
Industry
Financing
Details
Abzena Competitors (36)
One of Abzena’s 36 competitors is Alcyomics, a Formerly VC-backed company based in Newcastle upon Tyne, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Alcyomics | Formerly VC-backed | Newcastle upon Tyne, United Kingdom | ||||
| Celonic | Corporate Backed or Acquired | Basel, Switzerland | ||||
| Xoma | Corporate Backed or Acquired | Emeryville, CA | ||||
| Precigen | Formerly VC-backed | Germantown, MD | ||||
| AC Immune | Formerly VC-backed | Lausanne, Switzerland |
Abzena Patents
Abzena Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-201708105-D0 | Antibodies, uses thereof and conjugates thereof | Inactive | 19-May-2017 | ||
| US-10654873-B2 | Cytotoxic agents and conjugates thereof | Active | 15-Sep-2016 | ||
| ES-2882016-T3 | New cytotoxic agents and their conjugates | Active | 15-Sep-2016 | ||
| EP-3512856-A1 | Novel cytotoxic agents and conjugates thereof | Active | 15-Sep-2016 | ||
| EP-3512856-B1 | Novel cytotoxic agents and conjugates thereof | Active | 15-Sep-2016 | C07D498/18 |
Abzena Signals
Abzena Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Abzena Acquisitions (4)
Abzena’s most recent deal was a Merger/Acquisition with The Chemistry Research Solution for . The deal was made on 24-Nov-2015.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| The Chemistry Research Solution | 24-Nov-2015 | Merger/Acquisition | Biotechnology | ||
| Pacific GMP | 14-Sep-2015 | Merger/Acquisition | Laboratory Services (Healthcare) | ||
| Antitope | 26-Jul-2013 | Merger/Acquisition | Other Commercial Services | ||
| Warwick Effect Polymers | 20-Jan-2012 | Merger/Acquisition | Specialty Chemicals |
Abzena Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Antitope | Cambridge, United Kingdom | 2004 |
Abzena FAQs
-
When was Abzena founded?
Abzena was founded in 2001.
-
Where is Abzena headquartered?
Abzena is headquartered in Cambridge, United Kingdom.
-
What is the size of Abzena?
Abzena has 430 total employees.
-
What industry is Abzena in?
Abzena’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is Abzena a private or public company?
Abzena is a Private company.
-
What is Abzena’s current revenue?
The current revenue for Abzena is .
-
How much funding has Abzena raised over time?
Abzena has raised $122M.
-
Who are Abzena’s investors?
Beringea, Bloomsbury Bioseed Fund, Catapult Ventures, Comer Woodford Ventures, and IP Group are 5 of 16 investors who have invested in Abzena.
-
Who are Abzena’s competitors?
Alcyomics, Celonic, Xoma, Precigen, and AC Immune are some of the 36 competitors of Abzena.
-
When was Abzena acquired?
Abzena was acquired on 01-Feb-2026.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process